US 12064516
Pharmaceutical formulations and uses thereof
granted A61KA61K31/47A61K9/0053
Quick answer
US patent 12064516 (Pharmaceutical formulations and uses thereof) held by Aldeyra Therapeutics, Inc. expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aldeyra Therapeutics, Inc.
- Grant date
- Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/47, A61K9/0053, A61K9/0056, A61K9/141